Synthesis and in vitro anticancer activity of 4H-pyrano [2, 3-d] pyrimidine− 1H-1, 2, 3-triazole hybrid compounds bearing D-glucose moiety with dual EGFR/HER2 …

ND Thanh, NTK Giang, NTT Ha, CT Le, HTK Van… - Journal of Molecular …, 2023 - Elsevier
Abstracts The polysubstituted 4H-pyrano [2, 3-d] pyrimidines 6a-zj containing propargyl
group on nitrogen atom 3 of ring have been synthesized by ring-closing reaction of …

Synthesis and antiproliferative activity of 1 H-1, 2, 3-triazole-4 H-chromene-d-glucose hybrid compounds with dual inhibitory activity against EGFR/VEGFR-2 and …

DT Nguyen, SH Do, TH Le, TH Nguyen… - New Journal of …, 2022 - pubs.rsc.org
A series of 1H-1, 2, 3-triazole-4H-chromene-D-glucose hybrid compounds 7a-o was
synthesized via click chemistry using 2-amino-7-propargyloxy-4H-chromene-3-carbonitriles …

Synthesis and biological evaluation of novel [1, 2, 3] triazolo-pyrrolo [1, 2-a] pyrido [4, 3-d] pyrimidines as EGFR targeting anticancer agents

SR Bandi, N Kavitha, SK Nukala… - Journal of Molecular …, 2023 - Elsevier
Herein, we synthesized some new fused [1, 2, 3] triazolo-pyrrolo [1, 2-a] pyrido [4, 3-d]
pyrimidines via click chemistry followed by carbon-carbon bond coupling as key approach …

Synthesis, molecular modeling and biological evaluation of cinnamic acid derivatives with pyrazole moieties as novel anticancer agents

WM Zhang, M Xing, TT Zhao, YJ Ren, XH Yang… - RSC …, 2014 - pubs.rsc.org
A series of pyrazole derivatives (1e–30e) has been designed and synthesized, and their
biological activities were evaluated for EGFR and HER-2 inhibition and tumor cell …

Synthesis of novel pyrido [2, 3-d] pyrimidine-thiazolidine-1, 2, 3-triazoles: Potent EGFR targeting anticancer agents

SR Bandi, R Kapavarapu, R Palabindela… - Journal of Molecular …, 2023 - Elsevier
In this study, we designed and synthesized a number of novel pyrido [2, 3-d] pyrimidine-
thiazolidine-1, 2, 3-triazole derivatives and investigated them in vitro for their inhibitory …

Synthesis, anticancer activity and molecular docking of new pyrazolo [1, 5-a] pyrimidine derivatives as EGFR/HER2 dual kinase inhibitors

G Sivaiah, R Raveesha, SBB Prasad, KY Kumar… - Journal of Molecular …, 2023 - Elsevier
Abstract The pyrazolo [1, 5-a] pyrimidine core framework is a good starting point for the
synthesis of drug-like molecules since the biological activity is determined by the kind and …

Novel 1, 3, 5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: Synthesis, cytotoxicity, DNA binding, molecular docking …

MS Raghu, CBP Kumar, MK Prashanth… - New Journal of …, 2021 - pubs.rsc.org
We herein report the design and synthesis of new 1, 3, 5-triazine-based pyrazole derivatives
(5a–i) with anticancer activity targeting the epidermal growth factor (EGFR) tyrosine kinase …

Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers

SA Elmetwally, KF Saied, IH Eissa, EB Elkaeed - Bioorganic chemistry, 2019 - Elsevier
Deregulation of many kinases is directly linked to cancer development and the tyrosine
kinase family is one of the most important targets in current cancer therapy regimens. In this …

New Thiazolyl-Pyrazoline derivatives as potential dual EGFR/HER2 inhibitors: design, synthesis, anticancer activity evaluation and in silico study

MM Fakhry, AA Mattar, M Alsulaimany, EM Al-Olayan… - Molecules, 2023 - mdpi.com
A new series of thiazolyl-pyrazoline derivatives (4a–d, 5a–d 6a, b, 7a–d, 8a, b, and 10a, b)
have been designed and synthesized through the combination of thiazole and pyrazoline …

Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with …

WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi… - Scientific reports, 2022 - nature.com
Currently, the humanity is in a fierce battle against various health-related challenges
especially those associated with human malignancies. This created the urge to develop …